Q2 2013 13F Holders as of 30 Jun 2013
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
7,966,624
-
Share change
-
+73,662
-
Total reported value
-
$398,107,332
-
Price per share
-
$49.97
-
Number of holders
-
16
-
Value change
-
+$3,681,692
-
Number of buys
-
8
-
Number of sells
-
2
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q2 2013
As of 30 Jun 2013,
GLAXOSMITHKLINE PLC - ADR (GSK) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,966,624 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, CITADEL ADVISORS LLC, HUNTINGTON ASSET ADVISORS, INC., MUFG Americas Holdings Corp, HUNTINGTON NATIONAL BANK, Dixon Mitchell Investment Counsel Inc., Veritable, L.P., Elite Wealth Management, LLC, FTB Advisors, Inc., and Rehmann Capital Advisory Group.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.